Article

Effect of esberitox phytopreparation on factors of local immunity of the oral cavity

Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract

Introduction: Among a large number of immunomodulation agents, a special role belongs to herbal medicines. They differ in relative harmlessness and high efficiency, both with system and local use. Clinical and immunological efficacy of Esberitox phytopreparation (Schaper&Brummer, Germany) in a number of diseases of viral and microbial origin has been shown. This report presents data on the effect of Esberitox on the factors of local immunity of the oral cavity in patients with chronic pharyngitis, tonsillitis and periodontitis with systemic use of Esberitox in monotherapy. Methods: The oropharyngeal secret of 10 patients with chronic tonsillitis (CT), 11 patients with chronic pharyngitis (CP), (all patients after tonsillectomy), 10 patients with chronic periodontitis was investigated. Patients were given monotherapy with «Esberitox» for 10 days (CP), according to the manufacturer's instructions for use of the drug. In addition, 9 practically healthy persons (K) of the same age (18-50 years) were examined. The ELISA method was used to determine the class A immunoglobulins (secretory and monomeric), IgG, α-interferon, interleukin-1β, levels of immune complexes. Statistics: Mann-Whitney U-test. Results: Studies have shown that in patients with chronic inflammatory diseases of the oral cavity there is a decrease in the protective factors of local immunity – the level of secretory IgA, antiviral factor – α-interferon and an increase in the level of pro-inflammatory cytokine – interleukin-1β, monomeric form of IgA and the number of immune complexes. The use of «Esberitox» as a monotherapy was accompanied by an increase in the concentration of class A secretory immunoglobulin, the «normalization» of the α-interferon content (increase in concentration) and interleukin-1β (decrease in content). Conclusion: The resulting positive effects from the use of esberitox allow us to recommend the drug as part of the complex therapy of chronic diseases of the oropharynx, and in the form of monotherapy.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

ResearchGate has not been able to resolve any citations for this publication.
Article
The palatine and nasopharyngeal tonsils (adenoids) are lymphoepithelial tissues located in strategic anatomical areas of the oral pharynx and nasopharynx. These immunocompetent tissues represent the first line of defense against ingested or inhaled foreign proteins such as bacteria, viruses, or food antigens. Accompanying the advances being made in the field of medicine today, the role of the tonsils in immunocompetence is becoming extremely important. Upper respiratory tract infections such as acute otitis media, acute rhinosinusitis and acute pharyngo-tonsillitis are diseases that occur with extremely high frequency, and the antimicrobial agents used to treat these diseases account for a large proportion of health care costs. The increasingly refractory nature of upper respiratory tract infections caused by drug-resistant bacteria has become a major worldwide concern. The elucidation of the immune functions of the tonsils and mucosal membranes of the upper respiratory tract is considered to have important significance. The tonsils are also considered to play an important role as one of the causes of sleep apnea syndrome, and have been reported to be intimately involved in the manifestation of IgA nephropathy and palmoplantar pustulosis, a kind of skin disorder. Interest has continued to grow in this symposium with each session ever since it was first held in Kyoto, Japan in 1987. Since then, the symposium has been held every 3-4 years; in Pavia in 1991, in Sapporo in 1995, in Ghent in 1999, in Wakayama in 2003, and in Siena in 2006. Since the 5th symposium in Wakayama, the topics were extended to mucosal barriers of upper airways including the mucosal immune system, innate immunity, and mucosal vaccine. Recent fine technologies and information on molecular biological approaches for upper airways will continue to advance our understanding of epidemiology, etiology, pathogenesis, diagnosis and management of tonsil-related disorders and various upper respiratory tract infections such as otitis media and rhinosinusitis. Moreover, in the era of drug-resistant microbes, we should exert more effort to develop powerful and effective mucosal vaccines against pathogens in upper airways.
Article
Mucosal secretions contain a range of defense effector molecules including antimicrobial peptides and proteinase inhibitors. These molecules play a central role in host defense against infection, and in a variety of immune and inflammatory reactions. The aim of this study was to analyze the levels of neutrophil defensins, the cathelicidin hCAP-18/LL-37, and the proteinase inhibitors secretory leukocyte proteinase inhibitor, SKALP/elafin and cystatin M/E in various mucosal secretions and urine. We show here that especially seminal plasma is characterized by high concentrations of hCAP-18/LL-37, SLPI, SKALP/elafin and cystatin M/E. The results of this study demonstrate that each mucosal secretion is characterized by a unique profile of effector molecules, which may supply individual mucosal secretions with specific properties related to the control of local infection and inflammation.
Mathematical methods of analysis and recognition of pathological processes
  • E V Gubler
Gubler EV. [Mathematical methods of analysis and recognition of pathological processes]. Leningrad: Medicine; 1978. 294 p. [In Russian].
A study of the oropharyngeal secretion in patients with chronic inflammatory and allergic diseases of the upper respiratory tract: Guidelines
  • D I Zabolotny
  • O F Melnikov
  • S V Timchenko
  • D G Zabolotnaya
Zabolotny DI, Melnikov OF, Timchenko SV, Zabolotnaya DG. [A study of the oropharyngeal secretion in patients with chronic inflammatory and allergic diseases of the upper respiratory tract: Guidelines]. Kiev; 2008. 34 p. [In Ukrainian].
Cytokines and inflammation
  • F I Ershov
  • A N Norovlyansky
  • M V Mezentseva
Ershov FI, Norovlyansky AN, Mezentseva MV. [Early cytokine reactions in viral infections]. Cytokines and inflammation. 2004; 3 (1): 3-6. [Article in Russian].
Clinical immunology and allergology with the basics of general immunology
  • L V Kovalchuk
  • L V Gankovskaya
  • Meshkova Rya
Kovalchuk LV, Gankovskaya LV, Meshkova RYa. [Clinical immunology and allergology with the basics of general immunology]. Moscow: GEOTAR-Media; 2011. 640 p. [In Russian].
Kiev: Logos; 2017. 192 s
  • O F Melnikov
  • D I Zabolotny
  • V V Kischuk
  • A Y Bredun
  • O G Rylskaya
Melnikov OF, Zabolotny DI, Kischuk VV, Bredun AY, Rylskaya OG. [Immunology of chronic tonsillitis]. Kiev: Logos; 2017. 192 s. [In Russian].
Immunological aspects in the selection of tonsils pathology treatment methods. The 8 th International Symp
  • O Bredun
  • O Melnykov
Bredun O, Melnykov O. Immunological aspects in the selection of tonsils pathology treatment methods. The 8 th International Symp. of Tonsills. Zurich; 2013. abstr. 02.
The concept of diagnosing secondary immunodeficiency states based on determination of immunoglobulins in the secretions
  • O Melnykov
  • D Zabolotny
Melnykov O, Zabolotny D. The concept of diagnosing secondary immunodeficiency states based on determination of immunoglobulins in the secretions. Intern. Journal on Immunorehabilitation. 2004; 6(2): 235.